Vimarsana
Biggest News Aggregation in the World

Oliver Ernst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oliver Ernst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oliver Ernst Today - Breaking & Trending Today

NEUWAY Pharma GmbH: NEUWAY Pharma Appoints Dr Oliver Ernst as Chief Executive Officer and Dr Thomas Christoph as Chief Development Officer - Vimarsana News

NEUWAY Pharma GmbH: NEUWAY Pharma Appoints Dr Oliver Ernst as Chief Executive Officer and Dr Thomas Christoph as Chief Development Officer

NEUWAY Pharma GmbH, NEUWAY », a highly innovative biotechnology company specializing in the delivery of mRNA and other biotherapeutic drug molecules to the CNS and other tissues via its proprietary

NEUWAY Pharma GmbH: NEUWAY Pharma Appoints Healthcare Sector Veteran Dr Jacques Mallet to its Advisory Board - Vimarsana News

NEUWAY Pharma GmbH: NEUWAY Pharma Appoints Healthcare Sector Veteran Dr Jacques Mallet to its Advisory Board

Dr Jacques Mallet, former SVP of Portfolio Analytics/Corporate Strategy at Sanofi, joins NEUWAY's Advisory Board as independent member adding in depth expertise in pharma corporate development,

NEUWAY Pharma Appoints Healthcare Sector Veteran Dr Jacques Mallet to its Advisory Board - Vimarsana News

NEUWAY Pharma Appoints Healthcare Sector Veteran Dr Jacques Mallet to its Advisory Board

Dr Jacques Mallet, former SVP of Portfolio Analytics/Corporate Strategy at Sanofi, joins NEUWAY’s Advisory Board as independent member adding in depth expertise in pharma corporate development, financing and clinical affairsBONN, Germany--(BUSINESS WIRE)--#biotechnology--NEUWAY Pharma GmbH, « NEUWAY », a preclinical...

2022: Advancing across the blood-brain barrier - Vimarsana News

2022: Advancing across the blood-brain barrier

NEUWAY Pharma's targeted drug delivery technology, EnPC, which potentiates multi‑cargo BBB delivery including nucleic acid.

Related Topics:
Oliver ErnstHeiko Manninga